Skip to main content
Top
Published in: Drugs & Aging 8/2017

01-08-2017 | Original Research Article

Medication Use and Fall-Related Hospital Admissions from Long-Term Care Facilities: A Hospital-Based Case–Control Study

Authors: Taliesin E. Ryan-Atwood, Mieke Hutchinson-Kern, Jenni Ilomäki, Michael J. Dooley, Susan G. Poole, Carl M. Kirkpatrick, Elizabeth Manias, Biswadev Mitra, J. Simon Bell

Published in: Drugs & Aging | Issue 8/2017

Login to get access

Abstract

Background

Falls are a leading cause of preventable hospitalizations from long-term care facilities (LTCFs). Polypharmacy and falls-risk medications are potentially modifiable risk factors for falling.

Objective

This study investigated whether polypharmacy and falls-risk medications are associated with fall-related hospital admissions from LTCFs compared with hospital admissions for other causes.

Methods

This was a hospital-based, case–control study of patients aged ≥65 years hospitalized from LTCFs. Cases were patients with falls and fall-related injuries, and controls were patients admitted for infections. Conditional logistic regression was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between polypharmacy (defined as the use of nine or more regular pre-admission medications) and falls-risk medications (categorized as psychotropic medications and those that can cause orthostatic hypotension) with fall-related hospital admissions.

Results

There was no association between polypharmacy and fall-related hospital admissions (adjusted OR 0.97, 95% CI 0.63–1.48); however, the adjusted odds of fall-related hospital admissions increased by 16% (95% CI 3–30%) for each additional falls-risk medication. Medications that can cause orthostatic hypotension (adjusted OR 1.25, 95% CI 1.06–1.46), but not psychotropic falls-risk medications (adjusted OR 1.02, 95% CI 0.88–1.18) were associated with fall-related hospital admissions. The association between medications that can cause orthostatic hypotension and fall-related hospital admissions was strongest among residents with polypharmacy (adjusted OR 1.44, 95% CI 1.08–1.92).

Conclusion

Polypharmacy was not an independent risk factor for fall-related hospital admissions; however, medications that can cause orthostatic hypotension were associated with fall-related hospital admissions, particularly among residents with polypharmacy. Falls-risk should be considered when prescribing medications that can cause orthostatic hypotension.
Literature
1.
go back to reference Kalisch LM, Caughey GE, Barratt JD, et al. Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm. Int J Qual Health Care. 2012;24(3):239–49.CrossRefPubMed Kalisch LM, Caughey GE, Barratt JD, et al. Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm. Int J Qual Health Care. 2012;24(3):239–49.CrossRefPubMed
2.
go back to reference Tovell A, Harrison JE, Pointer S. Hospitalised injury in older Australians, 2011–12. Injury research and statistics series no. 90. Cat. No. Injcat 166. Canberra: Australian Institute of Health and Welfare; 2014. Tovell A, Harrison JE, Pointer S. Hospitalised injury in older Australians, 2011–12. Injury research and statistics series no. 90. Cat. No. Injcat 166. Canberra: Australian Institute of Health and Welfare; 2014.
3.
go back to reference Baranzini F, Diurni M, Ceccon F, et al. Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res. 2009;9:228.CrossRefPubMedPubMedCentral Baranzini F, Diurni M, Ceccon F, et al. Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res. 2009;9:228.CrossRefPubMedPubMedCentral
4.
go back to reference Cherubini A, Corsonello A, Lattanzio F. Polypharmacy in nursing home residents: what is the way forward? J Am Med Dir Assoc. 2016;17(1):4–6.CrossRefPubMed Cherubini A, Corsonello A, Lattanzio F. Polypharmacy in nursing home residents: what is the way forward? J Am Med Dir Assoc. 2016;17(1):4–6.CrossRefPubMed
6.
go back to reference Heinrich S, Rapp K, Rissmann U, et al. Cost of falls in old age: a systematic review. Osteoporos Int. 2010;21(6):891–902.CrossRefPubMed Heinrich S, Rapp K, Rissmann U, et al. Cost of falls in old age: a systematic review. Osteoporos Int. 2010;21(6):891–902.CrossRefPubMed
7.
go back to reference Bradley C. Trends in hospitalisations due to falls by older people, Australia 1999–00 to 2010–11. Injury research and statistics series 84. Canberra: Australian Institute of Health and Welfare; 2013. Bradley C. Trends in hospitalisations due to falls by older people, Australia 1999–00 to 2010–11. Injury research and statistics series 84. Canberra: Australian Institute of Health and Welfare; 2013.
8.
go back to reference Jokanovic N, Tan EC, Dooley MJ, et al. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1–12.CrossRef Jokanovic N, Tan EC, Dooley MJ, et al. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1–12.CrossRef
9.
go back to reference Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–8.CrossRefPubMed Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–8.CrossRefPubMed
10.
go back to reference Jokanovic N, Tan EC, Dooley MJ, et al. Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals. J Eval Clin Pract. 2016;22(5):677–82.CrossRefPubMed Jokanovic N, Tan EC, Dooley MJ, et al. Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals. J Eval Clin Pract. 2016;22(5):677–82.CrossRefPubMed
11.
go back to reference Wastesson JW, Canudas-Romo V, Lindahl-Jacobsen R, et al. Remaining life expectancy with and without polypharmacy: a register-based study of Swedes aged 65 years and older. J Am Med Dir Assoc. 2016;17(1):31–5.CrossRefPubMedPubMedCentral Wastesson JW, Canudas-Romo V, Lindahl-Jacobsen R, et al. Remaining life expectancy with and without polypharmacy: a register-based study of Swedes aged 65 years and older. J Am Med Dir Assoc. 2016;17(1):31–5.CrossRefPubMedPubMedCentral
12.
go back to reference Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.CrossRefPubMed Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.CrossRefPubMed
13.
go back to reference Runciman WB, Roughead EE, Semple SJ, et al. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.CrossRefPubMed Runciman WB, Roughead EE, Semple SJ, et al. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.CrossRefPubMed
14.
go back to reference Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.CrossRefPubMed Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.CrossRefPubMed
15.
go back to reference Olazarán J, Valle D, Serra JA, et al. Psychotropic medications and falls in nursing homes: a cross-sectional study. J Am Med Dir Assoc. 2013;14(3):213–7.CrossRefPubMed Olazarán J, Valle D, Serra JA, et al. Psychotropic medications and falls in nursing homes: a cross-sectional study. J Am Med Dir Assoc. 2013;14(3):213–7.CrossRefPubMed
16.
go back to reference Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209–20.CrossRefPubMedPubMedCentral Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209–20.CrossRefPubMedPubMedCentral
17.
go back to reference Lipsitz LA, Jonsson PV, Kelley MM, et al. Causes and correlates of recurrent falls in ambulatory frail elderly. J Gerontol. 1991;46(4):M114–22.CrossRefPubMed Lipsitz LA, Jonsson PV, Kelley MM, et al. Causes and correlates of recurrent falls in ambulatory frail elderly. J Gerontol. 1991;46(4):M114–22.CrossRefPubMed
18.
go back to reference Damián J, Pastor-Barriuso R, Valderrama-Gama E, et al. Factors associated with falls among older adults living in institutions. BMC Geriatr. 2013;13(1):1–9.CrossRef Damián J, Pastor-Barriuso R, Valderrama-Gama E, et al. Factors associated with falls among older adults living in institutions. BMC Geriatr. 2013;13(1):1–9.CrossRef
19.
go back to reference Park H, Satoh H, Miki A, et al. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–40.CrossRefPubMed Park H, Satoh H, Miki A, et al. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–40.CrossRefPubMed
20.
22.
go back to reference Sluggett JK, Ilomaki J, Seaman KL, et al. Medication management policy, practice and research in Australian residential aged care: current and future directions. Pharmacol Res. 2017;116:20–8.CrossRefPubMed Sluggett JK, Ilomaki J, Seaman KL, et al. Medication management policy, practice and research in Australian residential aged care: current and future directions. Pharmacol Res. 2017;116:20–8.CrossRefPubMed
24.
go back to reference Rothman KJ, Greenland S, Lash TL. Case–control studies. Encyclopedia of quantitative risk analysis and assessment. New Jersey: Wiley; 2008. Rothman KJ, Greenland S, Lash TL. Case–control studies. Encyclopedia of quantitative risk analysis and assessment. New Jersey: Wiley; 2008.
25.
go back to reference Bronskill SE, Gill SS, Paterson JM, et al. Exploring variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc. 2012;13(3):309.e15–21.CrossRef Bronskill SE, Gill SS, Paterson JM, et al. Exploring variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc. 2012;13(3):309.e15–21.CrossRef
29.
go back to reference Milos V, Bondesson Å, Magnusson M, et al. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;14(1):1–7.CrossRef Milos V, Bondesson Å, Magnusson M, et al. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;14(1):1–7.CrossRef
30.
go back to reference Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58(6):595–602.CrossRefPubMed Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58(6):595–602.CrossRefPubMed
31.
go back to reference Vu MQ, Weintraub N, Rubenstein LZ. Falls in the nursing home: are they preventable? J Am Med Dir Assoc. 2006;7(3 Suppl):S53–8.CrossRefPubMed Vu MQ, Weintraub N, Rubenstein LZ. Falls in the nursing home: are they preventable? J Am Med Dir Assoc. 2006;7(3 Suppl):S53–8.CrossRefPubMed
32.
go back to reference Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011;34(11–12):1269–81.CrossRefPubMed Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011;34(11–12):1269–81.CrossRefPubMed
33.
34.
go back to reference Jansen S, Bhangu J, de Rooij S, et al. The association of cardiovascular disorders and falls: a systematic review. J Am Med Dir Assoc. 2016;17(3):193–9.CrossRefPubMed Jansen S, Bhangu J, de Rooij S, et al. The association of cardiovascular disorders and falls: a systematic review. J Am Med Dir Assoc. 2016;17(3):193–9.CrossRefPubMed
35.
go back to reference Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015;175(6):989–95.CrossRefPubMed Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015;175(6):989–95.CrossRefPubMed
36.
go back to reference O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMed O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMed
37.
go back to reference Goeres LM, Williams CD, Eckstrom E, et al. Pharmacotherapy for hypertension in older adults: a systematic review. Drugs Aging. 2014;31(12):897–910.CrossRefPubMed Goeres LM, Williams CD, Eckstrom E, et al. Pharmacotherapy for hypertension in older adults: a systematic review. Drugs Aging. 2014;31(12):897–910.CrossRefPubMed
38.
go back to reference Pratt NL, Ramsay EN, Kalisch Ellett LM, et al. Association between use of multiple psychoactive medicines and hospitalization for falls: retrospective analysis of a large healthcare claim database. Drug Saf. 2014;37(7):529–35.CrossRefPubMedPubMedCentral Pratt NL, Ramsay EN, Kalisch Ellett LM, et al. Association between use of multiple psychoactive medicines and hospitalization for falls: retrospective analysis of a large healthcare claim database. Drug Saf. 2014;37(7):529–35.CrossRefPubMedPubMedCentral
39.
go back to reference Sterke CS, van Beeck EF, van der Velde N, et al. New insights: dose–response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947–55.CrossRefPubMed Sterke CS, van Beeck EF, van der Velde N, et al. New insights: dose–response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947–55.CrossRefPubMed
40.
go back to reference Callisaya ML, Sharman JE, Close J, et al. Greater daily defined dose of antihypertensive medication increases the risk of falls in older people: a population-based study. J Am Geriatr Soc. 2014;62(8):1527–33.CrossRefPubMed Callisaya ML, Sharman JE, Close J, et al. Greater daily defined dose of antihypertensive medication increases the risk of falls in older people: a population-based study. J Am Geriatr Soc. 2014;62(8):1527–33.CrossRefPubMed
43.
go back to reference Leung B, Jokanovic N, Tan EC, et al. Prescribed doses of opioids in long-term care facilities. J Am Med Dir Assoc. 2015;16(12):1100–2.CrossRefPubMed Leung B, Jokanovic N, Tan EC, et al. Prescribed doses of opioids in long-term care facilities. J Am Med Dir Assoc. 2015;16(12):1100–2.CrossRefPubMed
44.
go back to reference Australian Institute of Health and Welfare, Bradley C. Hospitalisations due to falls by older people, Australia 2009–2010. Canberra: Australian Institute of Health and Welfare; 2013. Australian Institute of Health and Welfare, Bradley C. Hospitalisations due to falls by older people, Australia 2009–2010. Canberra: Australian Institute of Health and Welfare; 2013.
45.
go back to reference Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med. 2002;18(2):141–58.CrossRefPubMed Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med. 2002;18(2):141–58.CrossRefPubMed
46.
go back to reference Ricci F, Manzoli L, Sutton R, et al. Hospital admissions for orthostatic hypotension and syncope in later life: insights from the Malmö preventive project. J Hypertens. 2017;35(4):776–83.CrossRefPubMed Ricci F, Manzoli L, Sutton R, et al. Hospital admissions for orthostatic hypotension and syncope in later life: insights from the Malmö preventive project. J Hypertens. 2017;35(4):776–83.CrossRefPubMed
47.
go back to reference Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668–71.CrossRefPubMed Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668–71.CrossRefPubMed
48.
go back to reference Cherubini A, Eusebi P, Dell’Aquila G, et al. Predictors of hospitalization in Italian nursing home residents: the U.L.I.S.S.E. project. J Am Med Dir Assoc. 2012;13(1):84.e5–10.CrossRef Cherubini A, Eusebi P, Dell’Aquila G, et al. Predictors of hospitalization in Italian nursing home residents: the U.L.I.S.S.E. project. J Am Med Dir Assoc. 2012;13(1):84.e5–10.CrossRef
49.
go back to reference Lalic S, Sluggett JK, Ilomaki J, et al. Polypharmacy and medication regimen complexity as risk factors for hospitalization among residents of long-term care facilities: a prospective cohort study. J Am Med Dir Assoc. 2016;17(11):1067.e1–6.CrossRef Lalic S, Sluggett JK, Ilomaki J, et al. Polypharmacy and medication regimen complexity as risk factors for hospitalization among residents of long-term care facilities: a prospective cohort study. J Am Med Dir Assoc. 2016;17(11):1067.e1–6.CrossRef
50.
go back to reference Turner JP, Jamsen KM, Shakib S, et al. Polypharmacy cut-points in older people with cancer: How many medications are too many? Support Care Cancer. 2016;24(4):1831–40.CrossRefPubMed Turner JP, Jamsen KM, Shakib S, et al. Polypharmacy cut-points in older people with cancer: How many medications are too many? Support Care Cancer. 2016;24(4):1831–40.CrossRefPubMed
51.
go back to reference Wimmer BC, Bell JS, Fastbom J, et al. Medication regimen complexity and number of medications as factors associated with unplanned hospitalizations in older people: a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2016;71(6):831–7.CrossRefPubMed Wimmer BC, Bell JS, Fastbom J, et al. Medication regimen complexity and number of medications as factors associated with unplanned hospitalizations in older people: a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2016;71(6):831–7.CrossRefPubMed
52.
go back to reference Berry SD, Mittleman MA, Zhang Y, et al. New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home. Pharmacoepidemiol Drug Saf. 2012;21(5):560–3.CrossRefPubMedPubMedCentral Berry SD, Mittleman MA, Zhang Y, et al. New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home. Pharmacoepidemiol Drug Saf. 2012;21(5):560–3.CrossRefPubMedPubMedCentral
Metadata
Title
Medication Use and Fall-Related Hospital Admissions from Long-Term Care Facilities: A Hospital-Based Case–Control Study
Authors
Taliesin E. Ryan-Atwood
Mieke Hutchinson-Kern
Jenni Ilomäki
Michael J. Dooley
Susan G. Poole
Carl M. Kirkpatrick
Elizabeth Manias
Biswadev Mitra
J. Simon Bell
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 8/2017
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-017-0472-8

Other articles of this Issue 8/2017

Drugs & Aging 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.